November 30th, 2021 was the date that marked the opening of the issue of Star Health IPO, which is supported by the chief investor, Rakesh Jhunjhunwala. The issue will remain open for 3 consecutive days till the 2nd of December, 2021. According to Star Health officials, the organization managed to collect an amount of 3,217 crores INR from the chief investor Rakesh Jhunjhunwala just before the opening date of the IPO.
Star Health’s share is estimated to be around 800 to 900 INR per share. The Alliance company, supported by the chief investor along with other investment institutions like Safecorp Investments India and West bridge, aims at collecting more than Rupees 7 crores from their initial issue. The initial public offering has been structured into two subdivisions by the Star Health organization. They have taken 5,249 and made it an issue that is supposed to be gained through a sale/offer. Out of this sale, above 58 lakhs of equity shares will be enjoyed equally amongst the promoters, benefactors, and shareholders of the organization. The remaining 2,000 crores will be offered as a novel issue.
Vodafone India in talks with banks for loan recast
Investing in Star Health IPO requires a minimum of 16 equity shares. On the other hand, Real Investors have 208n equity shares they can purchase. The minimum investment for retail investors will be 14,400 for one purchase, while the maximum goes up to 1,87,000 for 13 purchases/slots. Apart from the external share distribution, Star Health has reserved a share amount of Rupees 100 crores for its own employees.
The disadvantages of Star Health IPO are that they do not follow the parallel created by government policies and regulations. The insurance services of the health department have been affected by the pandemic. Hence, this field sources minimal interest opportunities that will affect the final output of the profit.
